D-Art Hospitals And Research Institute Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year, 2 Days
- Last Filing with ROC 31 Mar 2021
About D-Art Hospitals And Research Institute
D-Art Hospitals And Research Institute Private Limited (DHARIPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 February 2019 (Six years 2 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Service Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Mangesh Dhule, Subhangi Nagpure, and Sunil Thakkar serve as directors at the Company.
Company Details
-
Location
Nagpur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U93090MH2019PTC320519
-
Company No.
320519
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Feb 2019
-
Date of AGM
29 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at D-Art Hospitals And Research Institute?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mangesh Dhule
|
Director | 01-Feb-2019 | Current |
|
Subhangi Nagpure
|
Director | 01-Feb-2019 | Current |
|
Sunil Thakkar
|
Director | 01-Feb-2019 | Current |
Financial Performance of D-Art Hospitals And Research Institute.
Enhance accessibility to D-Art Hospitals And Research Institute's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of D-Art Hospitals And Research Institute?
Unlock access to D-Art Hospitals And Research Institute's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Celerity Lifescience And Healthcare Private LimitedMangesh Dhule is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at D-Art Hospitals And Research Institute?
Unlock and access historical data on people associated with D-Art Hospitals And Research Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of D-Art Hospitals And Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped D-Art Hospitals And Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.